π£ Our Early Career Advancement Fellowships are officially open for applications! π£
These awards will support the brightest and best early career blood cancer researchers as they begin their journey to independence. Full details on our website bloodcancer.org.uk/research/β¦
.@mvmateos makes a very important point - Frailty score is dynamic! Itβs important to reassess frailty- bone pain and renal impairment may change with treatment. Frailty is not one and done. #mmsm#EHA2024
From learning new #clinicaltrial skills to developing your own research project, #EHA Clinical Research Training in Hematology (#CRTH) is a chance to advance your #hematology career. Hear from C Lecat, past CRTH scholar about her experience π
Learn more: eha.fyi/CRTH25
We are looking for a new consultant colleague (10 PA, substantive NHS post). Great opportunity for anyone with an interest in myeloma who wants to join an academic centre. royalmarsden.nhs.uk/current-β¦
There will be opportunities to contribute to T- cell directed therapy service expansion and be involved in / lead clinical research - working with a great team! Feel free to free to contact me for further information or apply at link above.
Not sure if you can submit an abstract and join #EHA2024? If you are under 36, you may qualify for a travel or participation grant. Grant applications are available during regular abstract submission and close on March 1, 2024.
Submit an abstract: eha.fyi/EHA2024_abstracts
Protein shake! Amazing talk by @apwiita on Proteomics to ID new MM targets. Poss source of biomarkers / classification of disease. Can use protein βSurfaceomeβ to ID new targets /protein conformation differences specific to MM plasma cells for targeting #mmsm#IMS23@UCSFCancer
B cells gone Badβ¦ aberrant B cell differentiation as the origin of MM. 1q abnormalities detectable in pt B cells β> implications for FCRL5
Congratulations to Wen Zhou for this work and #IMS23 abstract prize ! #mmsm
π’ On #EuropeanMyelomaDay, our goal is to highlight the crucial importance of early diagnosis for better patient outcomes. 24% of patients will wait 5 months or more to get a #myeloma diagnosis. Learn more here: mpeurope.org/2023/09/27/24-oβ¦
Today is #EuropeanMyelomaDay!
MPE launched this effort to spotlight the needs of patients like Vincent Claus and tackle issues such as delayed diagnosis.
Watch the video to see how myeloma affects lives and learn how you can be part of the change.
#LearnShareChange
Problematic Progenitors: awesome work by @Dr_Rodg showing that MM relapse may be driven by B cells & pre-plasma cells. One of my fave abstracts this am, as I am convinced that the βMM stem cellβ is the π to cure #IMS23#mmsm
Outstanding plenary talk by Dr Peter Campbell highlighting complexity of mutational burden, T cell clones and selection pressures that inform clonal heterogeneity of in cancer - we have a lot to learn still about clinical/therapeutic implications in #mmsm#IMS23 - job is not done yet.